KaushalRShojaniaKGBatesDW.Effects of computerized physician order entry and clinical decision support systems on medication safety. Arch Intern Med. 2003;163:1409-1416.
2.
BatesDWCullenDJLairdNet al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274(1):29-34.
3.
WingardJRKubilisPLeeLet al. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis. 1999;29:1402-1407.
4.
AlexanderBWingardJ.Study of renal safety in amphotericin B lipid complex-treated patients. Clin Infect Disease. 2005;40:S414-S121.
5.
LlanosACiezaJBernardoJet al. Effect of salt supplementation on amphotericin B nephrotoxicity. Kidney Int. 1991;40:302-308.